Consulting for life sciences, biotech and pharma companies
Heidi is a biologist. She has worked in the field of cell signalling throughout her career, identifying signalling proteins and their functions. Heidi has led a research lab in Cambridge for over twenty years and published over 60 research papers. Her speciality is small GTPase signalling regulated by GEFs. Heidi’s lab identified a family of GEFs and showed how these proteins control the immune system, particularly in neutrophils, white blood cells that combat bacterial infections. Heidi has also worked in protein kinase, lipid kinase, and phospholipase biology and has experience in glucose metabolism and in neuronal plasticity. In addition, Heidi has collaborated widely with cancer research labs, as the proteins she discovered contribute to the development and spread of several types of cancer. Heidi is experienced in biochemistry, cell, and molecular biology techniques and in functional genomics. She consults in these areas for life sciences, biotech and pharma companies.
Thesis proofreading and editing for students in life sciences and related fields
Heidi has very much enjoyed the interactions with her students and is proud of the Master’s and PhD theses they produced. She is happy to offer help with thesis proofreading and editing in the life sciences and related fields.
PhD in Cell Biology, 1996
University Paris VII
MSc in Life Sciences, 1992
Weizmann Institute of Science
Diploma in Biology, 1991
Free University of Berlin
Current Role: Associate Group Leader
Past Roles:
Led a research lab studying signalling proteins for over twenty years and published over 60 research papers.
The small G protein family Rac has numerous regulators that integrate extracellular signals into tight spatiotemporal maps of its activity to promote specific cell morphologies and responses. Here, we have generated a mouse strain, Rac-FRET, which ubiquitously expresses the Raichu-Rac biosensor. It enables FRET imaging and quantification of Rac activity in live tissues and primary cells without affecting cell properties and responses. We assessed Rac activity in chemotaxing Rac-FRET neutrophils and found enrichment in leading-edge protrusions and unexpected longitudinal shifts and oscillations during protruding and stalling phases of migration. We monitored Rac activity in normal or disease states of intestinal, liver, mammary, pancreatic, and skin tissue, in response to stimulation or inhibition and upon genetic manipulation of upstream regulators, revealing unexpected insights into Rac signaling during disease development. The Rac-FRET strain is a resource that promises to fundamentally advance our understanding of Rac-dependent responses in primary cells and native environments.
For more information, contact Heidi at heidi@heidiwelchconsulting.com